Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDP.L Regulatory News (IDP)

  • There is currently no data for IDP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of Prolong in the US and Australia

1 May 2018 15:42

RNS Number : 7879M
InnovaDerma PLC
01 May 2018
 

LEI: 213800WRAP6W8VDL6B38

InnovaDerma PLC

Launch of ProlongTM, the world's only FDA-cleared medical device for premature ejaculation in the United States and Australia

Launch of smilingdick.com, a 'sex positive' platform for men that aims to de-stigmatise male sexual health issues

InnovaDerma (LSE: IDP), a UK developer of life sciences, beauty and personal care products, is pleased to provide the following update:

 

As outlined in the Company's interim results in January, the Company has now launched ProlongTM * -- the world's only FDA-cleared medical device for premature ejaculation in the United States and Australia. The launch is being supported by a highly creative marketing campaign including a website smilingdick.com, a new, first of its kind, ground-breaking sex-positive platform with the aim to normalise and de-stigmatise discussions around sexual health and wellbeing for men.

 

InnovaDerma conducted in-depth research with 4,000 men and women across Australia and the United States and the findings form the basis of the launch of Prolong and smilingdick.com. Most revealing findings were one in two men in the United States believe they suffer from premature ejaculation and in Australia, one in three.

 

The Company is seeking CE Mark regulatory approval for Prolong and once obtained, the device will be launched in the UK and Europe.

 

Haris Chaudhry, Executive Chairman said: "I am delighted to be launching ProlongTM, the world's only FDA-cleared medical device for premature ejaculation in the United States and Australia together with smilingdick.com. Sexual health issues have been considered a taboo subject for far too long, igniting shame and embarrassment in sufferers, which can manifest in various negative ways -- impacting mental wellbeing and relationships. Through Prolong and Smiling Dick, we aim to provide a non-prescription solution with long term benefits and a platform to help people feel open and supported in what should be a healthy and normal dialogue."

 

Dr Andy Zamar, Medical Director, Consultant Psychiatrist, Founder of The London Psychiatry Centre, and Creator of Prolong Device said: "A loss of sexual confidence can have a huge impact on mental wellbeing, being linked to increased mental health issues as well as substance and alcohol abuse. For lifelong sufferers of premature ejaculation, finding a permanent solution has previously been hugely costly and time consuming, with treatments limited to techniques like cognitive behavioural therapy. This has meant that many men have not been able to seek support, and have been left feeling isolated. Through this program, we're able to offer men a cost effective, permanent solution -- with no side effects -- which they can use in the privacy of their own home."

 

InnovaDerma

Haris Chaudhry/Joe Bayer

+61 (0)3 9111 0071

finnCap Ltd

Geoff Nash/Kate Bannatyne

Alice Lane - Corporate Broking

+44 (0) 20 7220 0500

www.finncap.com

TB Cardew

Shan Shan Willenbrock

Tom Allison

Alycia Macaskill

Joe McGregor

+ 44 (0)20 7930 0777

About InnovaDerma

InnovaDerma PLC (LSE: IDP) specializes in the research, manufacture and marketing of clinically proven products in life sciences, beauty and personal care products. InnovaDerma has presence in Europe, US, Australasia, Asia and Africa. 

To find out more about Smiling Dick and the Prolong Device and Climax Control Training Program, visit smilingdick.com.

 

*About the Prolong Device and Climax Control Training Program

· ProlongTM is a Class II vibrating medical device as classified by the FDA and used as part of a climax control program for males who suffer from premature ejaculation. It is designed to increase the time between arousal and ejaculation through the use of the training sessions using the stimulating vibratory effects of the device on the penis as part of the "Start-Stop" technique. Prolong offers an affordable, pain-free, one-off, or long-term treatment option with no side effects. The ProlongTM prototype delivered efficacy 338% above the combination of the Start-Stop technique with behaviour therapy alone, which is the current gold standard treatment for premature ejaculation. In a clinical trial in Finland which featured a group of lifelong sufferers of premature ejaculation, 70% of patients who failed on all known treatments including drug treatment, improved after being treated with ProlongTM and the improvement was either sustained or improved six months after completion of the treatment.

 

About smilingdick.com 

Smilingdick.com is a first-of-its-kind 'sex positive' platform for men, which hosts a range of sexual health content providing information and tips delivered through a positive, progressive, and inclusive lens. So why does Prolong want to help dicks smile? Sexual health issues like premature ejaculation have been considered taboo for far too long, igniting shame and embarrassment amongst sufferers, which can negatively impact not only relationships, but mental wellbeing as well. Through smilingdick.com, Prolong aims to pioneer a more progressive and positive discussion, and help people feel open, supported, and comfortable in what we think should be a healthy and normal dialogue.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABSGDUDXGBGIB
Date   Source Headline
8th Mar 201810:13 amRNSTrading Statement
15th Feb 20187:00 amRNSHalf-year Report
2nd Feb 20187:00 amRNSDirector/PDMR Shareholding
16th Jan 20187:00 amRNSTrading Statement
15th Dec 20177:00 amRNSIssue of Warrants and Issue of Equity
24th Nov 201711:37 amRNSHolding(s) in Company
10th Nov 20177:00 amRNSAllotment of Shares
8th Nov 201710:47 amRNSResult of AGM
8th Nov 20177:00 amRNSAGM Statement and Operational Update
7th Nov 20178:16 amRNSHolding(s) in Company
20th Oct 20177:53 amRNSAllotment of Shares
18th Oct 20179:52 amRNSASA Ruling
16th Oct 20177:00 amRNSAdmission of Shares
16th Oct 20177:00 amRNSHolding(s) in Company
12th Oct 20175:18 pmRNSNotice of AGM & Posting of Annual Report
12th Oct 201710:40 amRNSHolding(s) in Company
9th Oct 20177:00 amRNSTotal Voting Rights
6th Oct 20179:55 amRNSCompletion of Placing
6th Oct 20177:00 amRNSProposed Placing
2nd Oct 20177:00 amRNSAllotment of Shares
27th Sep 20177:00 amRNSOperational Update
14th Sep 20177:00 amRNSTransfer of Shares
12th Sep 20177:00 amRNSFinal Results
4th Sep 20177:00 amRNSOperational Update
11th Aug 20179:30 amRNSNotice of Results
28th Jul 201711:58 amRNSDirector/PDMR Shareholding
26th Jul 20172:22 pmRNSAllotment of Shares
26th Jul 20177:00 amRNSOperational Update
26th Jul 20177:00 amRNSDirectorate Change and Change Of Adviser
19th Jun 20174:40 pmRNSSecond Price Monitoring Extn
19th Jun 20174:35 pmRNSPrice Monitoring Extension
19th Jun 20172:05 pmRNSSecond Price Monitoring Extn
19th Jun 20172:00 pmRNSPrice Monitoring Extension
19th Jun 201711:05 amRNSSecond Price Monitoring Extn
19th Jun 201711:00 amRNSPrice Monitoring Extension
19th Jun 20179:05 amRNSSecond Price Monitoring Extn
19th Jun 20179:00 amRNSPrice Monitoring Extension
19th Jun 20178:18 amRNSTrading Statement (Replacement)
19th Jun 20177:00 amRNSTrading Statement
8th Jun 20177:00 amRNSExercise of Broker Warrants
1st Jun 20177:00 amRNSInnovaDerma secures Boots Ireland
22nd May 20172:05 pmRNSSecond Price Monitoring Extn
22nd May 20172:00 pmRNSPrice Monitoring Extension
22nd May 20177:00 amRNSLaunch of haircare range and entry into skincare
15th May 20179:47 amRNSHolding(s) in Company
10th May 20172:25 pmRNSHolding(s) in Company
10th May 20172:21 pmRNSHolding(s) in Company
8th May 20173:54 pmRNSAllotment of Shares
5th May 20174:40 pmRNSSecond Price Monitoring Extn
5th May 20174:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.